RISK-ADAPT Protocol in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Clinical trial NCT07645326 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07645326
- Sponsor
- Georgetown University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2032-08-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.